Screening for gene mutations in central nervous system metastases of non-small-cell lung cancer

Brain Pathol. 2018 Mar;28(2):295-297. doi: 10.1111/bpa.12519.

Authors

Marcin Nicoś¹, Paweł Krawczyk¹, Bożena Jarosz², Marek Sawicki³, Justyna Szumiło⁴, Tomasz Trojanowski², Janusz Milanowski¹

Affiliations

¹ Departments of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-954, Lublin, Poland.
² Departments of Neurosurgery and Pediatric Neurosurgery, Medical University of Lublin, 20-954, Lublin, Poland.
³ Department of Thoracic Surgery, Medical University of Lublin, 20-954, Lublin, Poland.
⁴ Department of Pathomorphology, Medical University of Lublin, 20-954, Lublin, Poland.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma / genetics
Adenocarcinoma / pathology
Antineoplastic Agents / therapeutic use
Carcinoma, Large Cell / genetics
Carcinoma, Large Cell / pathology
Carcinoma, Non-Small-Cell Lung / genetics*
Carcinoma, Non-Small-Cell Lung / pathology*
Carcinoma, Squamous Cell / genetics
Carcinoma, Squamous Cell / pathology
Central Nervous System Neoplasms / drug therapy
Central Nervous System Neoplasms / genetics*
Central Nervous System Neoplasms / secondary*
Female
Genetic Testing
Humans
Lung Neoplasms / genetics*
Lung Neoplasms / pathology*
Male
Middle Aged
Retrospective Studies
Smoking / genetics

Substances

Antineoplastic Agents